1. Home/
  2. Compounds/
  3. decitabine:navitoclax (2:1 mol/mol)

decitabine:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2decitabine:navitoclax (2:1 mol/mol)
PharmacoGx decitabine:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to decitabine:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA TIGD3 CTRPv2 pan-cancer AAC 0.19 3e-09
mRNA SLC18A2 CTRPv2 pan-cancer AAC 0.18 3e-09
mRNA HNRNPUL1 CTRPv2 pan-cancer AAC 0.19 3e-09
mRNA SEPT3 CTRPv2 pan-cancer AAC 0.2 4e-09
mRNA DHPS CTRPv2 pan-cancer AAC 0.2 4e-09
mRNA ZMYM3 CTRPv2 pan-cancer AAC 0.2 4e-09
mRNA ZBTB44 CTRPv2 pan-cancer AAC 0.2 4e-09
mRNA RUNDC3A CTRPv2 pan-cancer AAC 0.2 4e-09
mRNA SNAP25 CTRPv2 pan-cancer AAC 0.19 5e-09
mRNA ZNF260 CTRPv2 pan-cancer AAC 0.19 5e-09
Download CSV